Avant Garde award for Investigators conducting high risk/high reward research on HIV and Substance Use (or Substance Use Disorders)
This grant supports innovative, high-risk research by creative scientists tackling major challenges in HIV and substance use or substance use disorders, including early-stage investigators.
Funder: National Institutes of Health (NIH)
Due Dates: August 15, 2026 (estimated)
Funding Amounts: Award size and total program funding not yet specified; DP1 mechanism expected.
Summary: Supports high-risk, high-reward research on HIV in the context of substance use or substance use disorders, including for early stage investigators.
Key Information: This is a forecasted opportunity; application details will be released in a future Notice of Funding Opportunity (NOFO).
Description
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), is planning to announce a funding opportunity for pioneering, high-risk/high-reward research addressing major challenges in biomedical and behavioral research on HIV and substance use or substance use disorders (SUDs). The program seeks exceptionally creative scientists proposing transformative approaches to these intersecting fields. Early Stage Investigators (ESI) are encouraged to apply. This opportunity will utilize the DP1 activity code, which typically supports innovative, investigator-initiated research.
Applications are not being accepted at this time; this is an advance notice to allow potential applicants time to develop collaborations and responsive projects.
